NMPA Approval

Rivastigmine Transdermal Patch

Approval Number

国药准字HJ20200018

CompanyLuye Pharma AG

Registration Date

March 25, 2025

Previous Approval Numbers

H20200018

Drug Information

Generic Name

利斯的明透皮贴剂

Dosage Form

贴剂

Strength

4.6mg/24小时

Drug Type

化学药品

Registration Date

March 25, 2025

Expiry Date

March 24, 2030

Company Information

Applicant Company

Company NameLuye Pharma AG

Company Address

Am Windfeld 35, 83714 Miesbach

Manufacturing Company

Company NameLuye Pharma AG

Company Address

Am Windfeld 35, 83714 Miesbach

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

Privacy Policy
Terms & Conditions

© 2025 MedPath, Inc. All rights reserved.